These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Lisuride in parkinsonism. Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665 [TBL] [Abstract][Full Text] [Related]
16. [Lisuride in the treatment of Parkinson syndrome]. Filipová M; Roth B; Kás S; Macek Z; Rozsíval V; Karen P; Votavová M; Krejcová H Cesk Neurol Neurochir; 1987 Mar; 50(2):102-7. PubMed ID: 3581244 [No Abstract] [Full Text] [Related]
17. The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsy. Neophytides A; Lieberman AN; Goldstein M; Gopinathan G; Leibowitz M; Bock J; Walker R J Neurol Neurosurg Psychiatry; 1982 Mar; 45(3):261-3. PubMed ID: 7086448 [TBL] [Abstract][Full Text] [Related]
19. Dopamine agonists as primary treatment in Parkinson's disease. Rinne UK Adv Neurol; 1987; 45():519-23. PubMed ID: 3103394 [No Abstract] [Full Text] [Related]
20. Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's disease. Laihinen A; Rinne UK; Suchy I Acta Neurol Scand; 1992 Dec; 86(6):593-5. PubMed ID: 1481646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]